The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...

Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

For over a thousand people who undergo a stem cell or bone marrow transplant, survival comes at a cost: graft-versus-host disease (GvHD). 1 GvHD is a life-altering condition which affects 30 to 40 per ...

Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...

Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.

Post-transplant cyclophosphamide (PTCy) plus sirolimus and cyclosporine can improve some outcomes when compared to mycophenolate mofetil (MMF) plus sirolimus and cyclosporine as graft-vs-host disease ...

据悉，慢性排异在异基因造血干细胞移植后发生率为30%-70%，是异基因造血干细胞移植2年以上晚期非复发性死亡的首要原因，会累及皮肤、指甲、口腔、眼睛、胃肠道、肝脏、生殖器、关节筋膜或骨关节等多个组织和器官 。

多彩贵州网讯(本网记者 杨昌鼎)2月17日是移植物抗宿主病日(GVHD ...

2月17日，是移植物抗宿主病日（GVHD ...

罗依教授指出，cGVHD和移植的原发病复发问题是移植术后患者面临的两大挑战。其中，cGVHD由于早期症状多样且不典型，认知与关注不足，容易被漏诊误诊，超50%的患者在诊断时已是中至重度，严重影响生活质量。“但其实cGVHD只要遵循‘早筛、早诊、早治’ ...